KYTX: Transformative cell therapy shows durable efficacy and safety in multiple autoimmune diseases
Cell therapy for autoimmune diseases is advancing rapidly, with miv-cel showing strong efficacy and safety in stiff person syndrome, myasthenia gravis, and progressive MS. Regulatory progress, robust physician support, and a premium pricing strategy position the therapy for impactful launches and e…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.